| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |